Verona Pharma (VRNA) EBITDA (2020 - 2025)
Verona Pharma (VRNA) EBITDA from Mar 31, 2020 to Jun 30, 2025. The TTM Verona Pharma (VRNA) EBITDA is -$52M. You can adjust inflation or export chart.
Annual EBITDA
Quarterly EBITDA
Verona Pharma (VRNA) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -59.85% |
| 3 Years TTM | +0.77% |
| 5 Years TTM | +18.92% |
| All Time TTM | -7.96% |
Annual EBITDA change of Verona Pharma (VRNA)
| Year | EBITDA | Change |
|---|---|---|
| 2025 | $3.58M | -102.39% |
| 2024 | -$150M | +127.95% |
| 2023 | -$66M | +0.47% |
| 2022 | -$65M | +14.78% |
| 2021 | -$57M | -12.75% |
| 2020 | -$65M | +53.46% |
| 2019 | -$43M | N/A |